EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudieOpen Access · CC BY 4.0

Performance and workflow comparison of the VITEK MS PRIME and Bruker Biotyper MALDI-TOF MS systems

Rachel E Bosserman, Nicole J Tarlton, Kelly Alvarado, Brittany Roemmich, Melanie L Yarbrough iD

Journal of Clinical Microbiology · 13.08.2025 · 63 (8)

DOI: 10.1128/jcm.00211-25 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 13.08.2025. Verfasst von Rachel E Bosserman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Workflow, Bacteria, Yeasts. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: bioMérieux SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) is widely used for rapid identification of bacteria and yeast in clinical labs. The VITEK MS PRIME (“PRIME”) is the latest MALDI-TOF MS system from bioMérieux. This study evaluated PRIME’s performance and workflow timing against the MALDI Biotyper CA System by Bruker (“Biotyper”). We compared a collection of 154 bacteria and yeast clinical isolates from various specimen types using three methods: Biotyper target with a toothpick, PRIME target with the PICKME nib, and PRIME target with a loop. Positive blood culture isolates were also analyzed using these methods, with high-experience (HEU, n = 300) and low-experience users (LEU, n = 50) after short (6–8 h) and routine (18–24 h) incubation on agar plates. Workflow timing, from sample processing to organism identification, was assessed to identify time savings. PRIME identified 96% (PICKME) and 95% (Loop) of challenge isolates to genus level, compared with Biotyper at 99%. Short incubation of positive blood culture isolates demonstrated similar species-level identification rates across all methods (Biotyper: 84%, PRIME PICKME: 80%, PRIME Loop: 81%), although more repeats were needed compared with routine incubation. No difference in species identification occurred between users for any method at short incubation (89%–91%, HEU, vs 79%–85% LEU). Single-target process times were comparable for all methods (55–59 min), whereas PRIME methods had shorter hands-on times for analysis of multiple targets (Biotyper: 53 min, PRIME PICKME: 39 min, PRIME Loop: 40 min). These findings highlight the comparable performance of the PRIME and Biotyper systems while demonstrating the potential for time savings with PRIME workflows, particularly in high-throughput settings. IMPORTANCE This study provides a critical evaluation of the new VITEK MS PRIME MALDI-TOF MS system, comparing its performance and workflow efficiency against the Bruker MALDI Biotyper. The study investigates the success rate of isolate identification from short incubation of positive blood cultures, illustrating the utility of this technique for downstream workflows such as faster reporting of results for patient management and isolate identification for interpretation of rapid phenotypic AST. Analysis of different workflows demonstrated areas for potential time savings, particularly in high-throughput settings. These findings highlight the importance of optimizing MALDI-TOF MS workflows in the era of workforce shortages and lab centralization to enhance rapid pathogen identification and improve patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationWorkflowBacteriaYeastsHumansBacterial InfectionsTime Factors

Stichwörter der Autor:innen

MALDI BiotyperMALDI-TOF MSVITEK MS PRIME

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Melanie L Yarbrough

Förderung

  • bioMérieux SA

Zitieren

APA

Bosserman, R. E., Tarlton, N. J., Alvarado, K., Roemmich, B., & Yarbrough, M. L. (2025). Performance and workflow comparison of the VITEK MS PRIME and Bruker Biotyper MALDI-TOF MS systems. Journal of Clinical Microbiology, 63(8). https://doi.org/10.1128/jcm.00211-25

Vancouver

Bosserman RE, Tarlton NJ, Alvarado K, Roemmich B, Yarbrough ML. Performance and workflow comparison of the VITEK MS PRIME and Bruker Biotyper MALDI-TOF MS systems. Journal of Clinical Microbiology. 2025;63(8). doi:10.1128/jcm.00211-25

BibTeX
@article{Bosserman2025,
  author = {Bosserman, Rachel E and Tarlton, Nicole J and Alvarado, Kelly and Roemmich, Brittany and Yarbrough, Melanie L},
  title = {Performance and workflow comparison of the VITEK MS PRIME and Bruker Biotyper MALDI-TOF MS systems},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  volume = {63},
  number = {8},
  doi = {10.1128/jcm.00211-25}
}
Kostenlos starten →